Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus

Lupus Erythematosus ◽

Polymorphonuclear Neutrophils ◽

Systemic Lupus ◽

Ion Transporter ◽

Transporter Expression

DEFECTIVE SPONTANEOUS AND BACTERIAL LIPOPOLYSACCHARIDE-STIMULATED PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST BY POLYMORPHONUCLEAR NEUTROPHILS OF PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

Rheumatology ◽

10.1093/rheumatology/34.2.107 ◽

1995 ◽

Vol 34 (2) ◽

pp. 107-112 ◽

Cited By ~ 7

Author(s):

S.-C. HSIEH ◽

C.-Y. TSAI ◽

K.-H. SUN ◽

Y.-Y. TSAI ◽

S.-T. TSAI ◽

...

Keyword(s):

Receptor Antagonist ◽

Lupus Erythematosus ◽

Interleukin 1 ◽

Bacterial Lipopolysaccharide ◽

Polymorphonuclear Neutrophils ◽

Systemic Lupus ◽

Interleukin 1 Receptor Antagonist

Enhanced Fc receptor function of monocytes from patients with clinically active systemic lupus erythematosus : Binding and degradation of soluble immune complexes in vitro.

Japanese Journal of Medicine ◽

10.2169/internalmedicine1962.25.263 ◽

1986 ◽

Vol 25 (3) ◽

pp. 263-269 ◽

Cited By ~ 1

Author(s):

Teizo KABASHIMA ◽

Tetsushi SAKURAI ◽

Kazuhide YAMANE ◽

Ichiro KONO ◽

Heihachiro KASHIWAGI

Keyword(s):

Lupus Erythematosus ◽

Immune Complexes ◽

Fc Receptor ◽

Receptor Function ◽

Systemic Lupus ◽

Soluble Immune Complexes

Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus—In vitro immune response to autoantigen

Clinical Immunology and Immunopathology ◽

10.1016/0090-1229(79)90060-6 ◽

1979 ◽

Vol 13 (2) ◽

pp. 161-170 ◽

Cited By ~ 43

Author(s):

Chikao Morimoto ◽

Tohru Abe ◽

Mitsuo Homma

Keyword(s):

Immune Response ◽

T Lymphocytes ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

Suppressor T Lymphocytes ◽

In Vitro Immune Response

INCREASED SPONTANEOUS RELEASE OF CYTIDINE DEAMINASE BY POLYMORPHONUCLEAR NEUTROPHILS OF PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

Rheumatology ◽

10.1093/rheumatology/31.10.675 ◽

1992 ◽

Vol 31 (10) ◽

pp. 675-678 ◽

Cited By ~ 5

Author(s):

C.-L. YU ◽

C.-Y. TSAI ◽

K.-H. SUN ◽

Y.-S. CHEN ◽

W.-M. LIN ◽

...

Keyword(s):

Lupus Erythematosus ◽

Cytidine Deaminase ◽

Polymorphonuclear Neutrophils ◽

Spontaneous Release ◽

Systemic Lupus

ASSESSMENT OF PERIPHERAL BLOOD В-CELL SUBSETS IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS AFTER RITUXIMAB TREATMENT

10.26226/morressier.56e174d5d462b8028d88a966 ◽

2016 ◽

Author(s):

Ekaterina Suponitskaya

Keyword(s):

Lupus Erythematosus ◽

Peripheral Blood ◽

Systemic Lupus

Studies of macrophage function in murine systemic lupus erythematosus. 4. failure to reverse the defect in fc-mediated phagocytosis and binding by in vitro stimulants or prostaglandins

Pathology ◽

10.3109/00313028609090829 ◽

1986 ◽

Vol 18 (1) ◽

pp. 59-63 ◽

Cited By ~ 1

Author(s):

Pamela J. Russell ◽

F.H. Cameron

Keyword(s):

Murine Systemic Lupus Erythematosus

Lupus Erythematosus ◽

Systemic Lupus ◽

Macrophage Function ◽

Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)

Case Medical Research ◽

10.31525/ct1-nct04058028 ◽

2019 ◽

Author(s):

Keyword(s):

Lupus Erythematosus ◽

Efficacy And Safety ◽

Systemic Lupus

Faculty Opinions recommendation of Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1109393.565439 ◽

2008 ◽

Author(s):

Robert Lafyatis

Keyword(s):

T Cells ◽

Regulatory T Cells ◽

Interferon Alpha ◽

Lupus Erythematosus ◽

Antigen Presenting Cells ◽

Systemic Lupus ◽

Antigen Presenting

Faculty Opinions recommendation of Effects of belimumab on flare rate and expected damage progression in patients with active systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727158446.793557815 ◽

2019 ◽

Author(s):

Victoria Werth

Keyword(s):

Lupus Erythematosus ◽

Systemic Lupus ◽

Damage Progression

Faculty Opinions recommendation of Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737043169.793576809 ◽

2020 ◽

Author(s):

Tak Mao Chan ◽

Susan Yung

Keyword(s):

Lupus Erythematosus ◽

Type I Interferon ◽

Type I ◽

Systemic Lupus ◽

Phase 3 ◽

Randomised Controlled